2015 Advocacy Efforts

 

October 2015

Moderated afternoon session of Rep. Susan W. Brooks, “Connecting Classrooms and Careers” program.

September 2015

Signed on to a joint letter to the President urging him to focus on ag biotech issues in his upcoming meetings with President Xi Jinping of China.

August 2015

Participated with IMDMC in Legislative Roundtable, Indianapolis

July 2015

Participated in Hoosiers Work for Health/We Work for Health PhRMA Partnership Fly-In to Washington D.C.

June 2015

Requested Indiana Congressional Delegation to sign-on to bi-partisan letter encouraging fair and balanced patent reform consideration in HR 9.

Met with Rep. Susan W. Brooks at BIO Convention in Philadelphia, provided tour of Indiana booth in the conference exhibit hall

May 2015

Awarded Rep. Susan W. Brooks IHIF’s Legislator of the Year Award for outstanding service to Indiana’s health science sector

Signed on to joint-association letter supporting H.R. 1078, the FDA Safety Over Sequestration (SOS) Act

Participated in Hoosiers Work for Health Award to Rep. Susan W. Brooks

Signed on to Healthcare Leadership Forum letter to repeal IPAB

April 2015

Participated in the BIO Fly-In to Washington, D.C. – met with nine of Indiana’s eleven offices.

March 2015

Signed on to the Declaration Supporting Incentives for Medical Innovation in Trade Agreements organized by the Global Colon Cancer Association and the Information Technology and Innovation Foundation

February 2015

Indiana Expanding Exports and Creating Jobs – Fact Sheet with information on TTIP and TPA impacts on state.

Signed on to National Osteoporosis Foundation letter to Congress supporting Medicare Part D.

January 2015

IHF signed on to a letter to the Administration emphasizing the importance of strong IP and data protections for medicines.  Letter was initiated by the Global Colon Cancer Association and the Information Technology and Innovation Foundation.

IHIF co-hosted our 4th Annual Legislative Breakfast Briefing (agenda) on January 28th.  Co-Hosts include IMDMC and Hoosiers Work for Health/PhRMA

IHIF shared concerns over Senator Elizabeth Warren’s “Medical Innovation Act”.

IHIF provided informational testimony on HB 1065 – Use of investigational drugs, biologics, and devices.  Also expressed concern over SB 66.

IHIF signs on to letter encouraging US legislators to proceed with caution when considering making changes to patent legislation

IHIF signs on to letter to US legislators highlighting the success of Medicare Part D and urging Congress to reject any proposals that would undermine the current program’s success in holding down premiums and taxpayer costs, while still producing high satisfaction rates among enrollees.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: